Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04794478 · ClinicalTrials.gov registry record · NA
Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) System
A NA study, sponsored by DexCom.
- Completed
- Registry status
- NA
- Development phase
- 482
- Enrollment target
NCT04794478 is a NA study that has completed, run by DexCom. The registered enrollment target is 482 participants.
The verdict
NCT04794478, a NA study, has completed, sponsored by DexCom.
- COMPLETED
- Registry status
- NA
- Development phase
- 482 participants
- Enrollment target
Study Summary
Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System
Interventions
- DEVICE Dexcom Continuous Glucose Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 482 participants |
| Start Date | 2021-02-19 |
| Est. Completion | 2021-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04794478
The ClinicalTrials.gov registry entry for NCT04794478 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 482 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is DexCom, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dexcom Continuous Glucose Monitoring System is the first listed.
NCT04794478 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04794478 about?
NCT04794478 is a clinical study titled "Evaluation of the Safety and Effectiveness of the Dexcom Continuous Glucose Monitoring (CGM) System". Evaluation of the Safety and Effectiveness of the Dexcom Glucose Monitoring (CGM) System
What is the current status of trial NCT04794478?
This trial is currently completed. It is a NA study. The enrollment target is 482 participants. The study started on 2021-02-19. Estimated completion is 2021-10-31.
What interventions are being tested in trial NCT04794478?
The interventions under investigation include: Dexcom Continuous Glucose Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT04794478?
This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.